Followers | 123 |
Posts | 16736 |
Boards Moderated | 1 |
Alias Born | 07/21/2006 |
![](https://investorshub.advfn.com/uicon/77759.png?cb=1639544075)
Thursday, January 28, 2021 11:29:24 AM
Recent VIR News
- Vir Biotechnology Receives FDA IND Clearance and Fast Track Designation for Tobevibart and Elebsiran for the Treatment of Chronic Hepatitis Delta Infection • Business Wire • 06/26/2024 12:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:00:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 10:04:32 AM
- Tobevibart Monotherapy and Combination Therapy with Elebsiran Achieved High Virologic Response and ALT Normalization in People Living with the Hepatitis Delta Virus After 12 and 24 Weeks of Treatment • Business Wire • 06/05/2024 09:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 04:13:41 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 03:57:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/31/2024 06:43:18 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/31/2024 06:42:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 08:06:02 PM
- Vir Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference • Business Wire • 05/29/2024 08:05:00 PM
- Vir Biotechnology Appoints Mark Eisner, M.D., M.P.H. as Chief Medical Officer • Business Wire • 05/29/2024 12:05:00 PM
- Vir Biotechnology to Host 2024 Annual Meeting of Stockholders • Business Wire • 05/23/2024 08:05:00 PM
- Multiple Abstracts Highlighting Vir Biotechnology’s Latest Hepatitis Delta & B Data Accepted for Presentation at the EASL Congress 2024 • Business Wire • 05/22/2024 12:05:00 PM
- Vir Biotechnology Announces SOLSTICE Data to be Featured as an Oral Presentation at the European Association for the Study of the Liver (EASL) Congress 2024 • Business Wire • 05/21/2024 12:17:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/14/2024 08:05:39 PM
- Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results • Business Wire • 05/02/2024 08:05:00 PM
- Vir Biotechnology to Participate in the BofA Securities Healthcare Conference 2024 • Business Wire • 04/30/2024 08:05:00 PM
- Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors • Business Wire • 04/18/2024 12:00:00 PM
- Vir Biotechnology to Provide Business Update and Report First Quarter 2024 Financial Results on May 2, 2024 • Business Wire • 04/11/2024 08:30:00 PM
- Vir Biotechnology Completes Enrollment of Phase 2 Chronic Hepatitis Delta SOLSTICE Trial Ahead of Schedule • Business Wire • 03/05/2024 01:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 12:34:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 12:32:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 12:32:19 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 12:31:36 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/26/2024 09:27:18 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM